Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
•Immunocompromised patients require combined antiviral therapies.•In vitro synergies exist for small molecule antivirals and passive immunotherapies.•Anti-spike monoclonal antibodies lost efficacy against recent Omicron variants.•Small molecule antivirals can be combined with increased efficacy.•Com...
Saved in:
Published in | International journal of infectious diseases Vol. 137; pp. 55 - 59 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.12.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!